|
||||||||||||||||||||||||||
| SEC Info℠ | | | Home | | | Search | | | My Interests | | | Help | | | Sign In | | | Please Sign In | |||||||
|
||||||||||||||||||||||||||
As Of Filer Filing For·On·As Docs:Size Issuer Agent 9/25/03 Angiotech Pharmaceuticals Inc F-10/A 8:711K Merrill Corp/New/FA |
Document/Exhibit Description Pages Size
1: F-10/A Pre-Effective Amendment to Registration Statement HTML 373K
of a Foreign Private Issuer (Not
Effective Immediately)
2: EX-3.1 Articles of Incorporation/Organization or By-Laws HTML 270K
3: EX-5.1 Opinion re: Legality HTML 8K
4: EX-5.2 Opinion re: Legality HTML 8K
5: EX-5.3 Opinion re: Legality HTML 8K
6: EX-5.4 Opinion re: Legality HTML 9K
7: EX-5.5 Opinion re: Legality HTML 7K
8: EX-5.6 Opinion re: Legality HTML 7K
| Page | (sequential) | | | (alphabetic) | Top | |
|---|---|---|---|---|---|
| 1 | 1st Page - Filing Submission | ||||
| " | Consent of Ernst & Young Llp, Independent Auditors | ||||
| " | QuickLinks | ||||
Exhibit 5.2
CONSENT OF ERNST & YOUNG LLP, INDEPENDENT AUDITORS
We consent to the reference to our firm under the caption "Experts" in Amendment No. 1 to the Registration Statement (Form F-10) and Prospectus of Angiotech Pharmaceuticals, Inc. for the registration of shares of its common stock and to the incorporation by reference therein of our report dated March 7, 2003, except for Note 17 as to which the date is September 18, 2003, included in the Current Report (Form 6-K) of Angiotech Pharmaceuticals, Inc., filed with the Securities and Exchange Commission.
Palo Alto, California |
/s/ ERNST & YOUNG LLP |
|
| September 25, 2003 |
| This ‘F-10/A’ Filing | Date | Other Filings | ||
|---|---|---|---|---|
 | ||||
| Filed on: | 9/25/03 | CORRESP | ||
| 9/18/03 | 6-K, F-10, F-X | |||
| 3/7/03 | ||||
| List all Filings | ||||